Libya

Africa

Contents

1. Regulatory Overview
2. Regulatory Pathways

Regulatory Overview

Libya is regulated by the NCDC (National Centre for Disease Control). The country has 1 documented regulatory pathway for accessing unapproved or unlicensed medicines, covering named patient programs, compassionate use schemes, and special access arrangements.

Regulatory Authority

NCDC (National Centre for Disease Control)

Regulatory Pathways (1)

Libya MOH Special Import Authorization 45 days

Libya Ministry of Health special import authorization for unregistered medicines for patients with serious or life-threatening conditions.

Application Form: MOH Libya Special Import Form

Legal Basis: Regulated

Eligibility: Serious or life-threatening condition with no locally registered alternative

Libya

ISO Code	`LY`
Region	Africa
Regulatory Authority	NCDC (National Centre for Disease Control)
Pathways	1 documented
Drugs Available	0 documented